#Family Advocacy Clinician

[nationwidechildrenshospital]

"In my current role, my primary responsibility is to provide individual mental health therapy to adults who have experienced domestic violence. I love working in this role because I believe helping individuals improve their day to day life by learning coping skills and processing the trauma they have experienced, will reduce the prevalence of generational trauma."

Amanda Danison, Family Advocacy Clinician II, The Center for Family Safety and Healing

[religion-is-a-mental-illness]

By: Azeen Ghorayshi

Published: May 13, 2024

After 30 years as one of England’s top pediatricians, Dr. Hilary Cass was hoping to begin her retirement by learning to play the saxophone.

Instead, she took on a project that would throw her into an international fire: reviewing England’s treatment guidelines for the rapidly rising number of children with gender distress, known as dysphoria.

At the time, in 2020, England’s sole youth gender clinic was in disarray. The waiting list had swelled, leaving many young patients waiting years for an appointment. Staff members who said they felt pressure to approve children for puberty-blocking drugs had filed whistle-blower complaints that had spilled into public view. And a former patient had sued the clinic, claiming that she had transitioned as a teenager “after a series of superficial conversations with social workers.”

The National Health Service asked Dr. Cass, who had never treated children with gender dysphoria but had served as the president of the Royal College of Pediatrics and Child Health, to independently evaluate how the agency should proceed.

Over the next four years, Dr. Cass commissioned systematic reviews of scientific studies on youth gender treatments and international guidelines of care. She also met with young patients and their families, transgender adults, people who had detransitioned, advocacy groups and clinicians.

Her final report, published last month, concluded that the evidence supporting the use of puberty-blocking drugs and other hormonal medications in adolescents was “remarkably weak.” On her recommendation, the N.H.S. will no longer prescribe puberty blockers outside of clinical trials. Dr. Cass also recommended that testosterone and estrogen, which allow young people to develop the physical characteristics of the opposite sex, be prescribed with “extreme caution.”

Dr. Cass’s findings are in line with several European countries that have limited the treatments after scientific reviews. But in America, where nearly two dozen states have banned the care outright, medical groups have endorsed the treatments as evidence-based and necessary.

The American Academy of Pediatrics declined to comment on Dr. Cass’s specific findings, and condemned the state bans. “Politicians have inserted themselves into the exam room, which is dangerous for both physicians and for families,” Dr. Ben Hoffman, the organization’s president, said.

The Endocrine Society told The New York Times that Dr. Cass’s review “does not contain any new research” that would contradict its guidelines. The federal health department did not respond to requests for comment.

Dr. Cass spoke to The Times about her report and the response from the United States. This conversation has been edited and condensed for clarity.

What are your top takeaways from the report?

The most important concern for me is just how poor the evidence base is in this area. Some people have questioned, “Did we set a higher bar for this group of young people?” We absolutely didn’t. The real problem is that the evidence is very weak compared to many other areas of pediatric practice.

The second big takeaway for me is that we have to stop just seeing these young people through the lens of their gender and see them as whole people, and address the much broader range of challenges that they have, sometimes with their mental health, sometimes with undiagnosed neurodiversity. It’s really about helping them to thrive, not just saying “How do we address the gender?” in isolation.

You found that the quality of evidence in this space is “remarkably weak.” Can you explain what that means?

The assessment of studies looks at things like, do they follow up for long enough? Do they lose a lot of patients during the follow-up period? Do they have good comparison groups? All of those assessments are really objective. The reason the studies are weak is because they failed on one or more of those areas.

The most common criticism directed at your review is that it was in some way rigged because of the lack of randomized controlled trials, which compare two treatments or a treatment and a placebo, in this field. That, from the get-go, you knew you would find that there was low-quality evidence.

People were worried that we threw out anything that wasn’t a randomized controlled trial, which is the gold standard for study design. We didn’t, actually.

There weren’t any randomized controlled trials, but we still included about 58 percent of the studies that were identified, the ones that were high quality or moderate quality. The kinds of studies that aren’t R.C.T.s can give us some really good information, but they have to be well-conducted. The weakness was many were very poorly conducted.

There’s something I would like to say about the perception that this was rigged, as you say. We were really clear that this review was not about defining what trans means, negating anybody’s experiences or rolling back health care.

There are young people who absolutely benefit from a medical pathway, and we need to make sure that those young people have access — under a research protocol, because we need to improve the research — but not assume that that’s the right pathway for everyone.

[ The Tavistock Gender Identity Development Service in London, which until recently was the National Health Service’s sole youth gender clinic in England. ]

Another criticism is that this field is being held to a higher standard than others, or being exceptionalized in some way. There are other areas of medicine, particularly in pediatrics, where doctors practice without high-quality evidence.

The University of York, which is kind of the home of systematic reviews, one of the key organizations that does them in this country, found that evidence in this field was strikingly lower than other areas — even in pediatrics.

I can’t think of any other situation where we give life-altering treatments and don’t have enough understanding about what’s happening to those young people in adulthood. I’ve spoken to young adults who are clearly thriving — a medical pathway has been the right thing for them. I’ve also spoken to young adults where it was the wrong decision, where they have regret, where they’ve detransitioned. The critical issue is trying to work out how we can best predict who’s going to thrive and who’s not going to do well.

In your report, you are also concerned about the rapid increase in numbers of teens who have sought out gender care over the last 10 years, most of whom were female at birth. I often hear two different explanations. On the one hand, there’s a positive story about social acceptance: that there have always been this many trans people, and kids today just feel freer to express who they are. The other story is a more fearful one: that this is a ‘contagion’ driven in large part by social media. How do you think about it?

There’s always two views because it’s never a simple answer. And probably elements of both of those things apply.

It doesn’t really make sense to have such a dramatic increase in numbers that has been exponential. This has happened in a really narrow time frame across the world. Social acceptance just doesn’t happen that way, so dramatically. So that doesn’t make sense as the full answer.

But equally, those who say this is just social contagion are also not taking account of how complex and nuanced this is.

Young people growing up now have a much more flexible view about gender — they’re not locked into gender stereotypes in the way my generation was. And that flexibility and fluidity are potentially beneficial because they break down barriers, combat misogyny, and so on. It only becomes a challenge if we’re medicalizing it, giving an irreversible treatment, for what might be just a normal range of gender expression.

What has the response to your report been like in Britain?

Both of our main parties have been supportive of the report, which has been great.

We have had a longstanding relationship with support and advocacy groups in the U.K. That’s not to say that they necessarily agree with all that we say. There’s much that they are less happy about. But we have had an open dialogue with them and have tried to address their questions throughout.

I think there is an appreciation that we are not about closing down health care for children. But there is fearfulness — about health care being shut down, and also about the report being weaponized to suggest that trans people don’t exist. And that’s really disappointing to me that that happens, because that’s absolutely not what we’re saying.

I’ve reached out to major medical groups in the United States about your findings. The American Academy of Pediatrics declined to comment on your report, citing its own research review that is underway. It said that its guidance, which it reaffirmed last year, was “grounded in evidence and science.”

The Endocrine Society said “we stand firm in our support of gender-affirming care,” which is “needed and often lifesaving.”

I think for a lot of people, this is kind of dizzying. We have medical groups in the United States and Britain looking at the same facts, the same scientific literature, and coming to very different conclusions. What do you make of those responses?

When I was president of the Royal College of Pediatrics and Child Health, we did some great work with the A.A.P. They are an organization that I have enormous respect for. But I respectfully disagree with them on holding on to a position that is now demonstrated to be out of date by multiple systematic reviews.

It wouldn’t be too much of a problem if people were saying “This is clinical consensus and we’re not sure.” But what some organizations are doing is doubling down on saying the evidence is good. And I think that’s where you’re misleading the public. You need to be honest about the strength of the evidence and say what you’re going to do to improve it.

I suspect that the A.A.P., which is an organization that does massive good for children worldwide, and I see as a fairly left-leaning organization, is fearful of making any moves that might jeopardize trans health care right now. And I wonder whether, if they weren’t feeling under such political duress, they would be able to be more nuanced, to say that multiple truths exist in this space — that there are children who are going to need medical treatment, and that there are other children who are going to resolve their distress in different ways.

Have you heard from the A.A.P. since your report was published?

They haven’t contacted us directly — no.

Have you heard from any other U.S. health bodies, like the Department of Health and Human Services, for example?

No.

Have you heard from any U.S. lawmakers?

No. Not at all.

Pediatricians in the United States are in an incredibly tough position because of the political situation here. It affects what doctors feel comfortable saying publicly. Your report is now part of that evidence that they may fear will be weaponized. What would you say to American pediatricians about how to move forward?

Do what you’ve been trained to do. So that means that you approach any one of these young people as you would any other adolescent, taking a proper history, doing a proper assessment and maintaining a curiosity about what’s driving their distress. It may be about diagnosing autism, it may be about treating depression, it might be about treating an eating disorder.

What really worries me is that people just think: This is somebody who is trans, and the medical pathway is the right thing for them. They get put on a medical pathway, and then the problems that they think were going to be solved just don’t go away. And it’s because there’s this overshadowing of all the other problems.

So, yes, you can put someone on a medical pathway, but if at the end of it they can’t get out of their bedroom, they don’t have relationships, they’re not in school or ultimately in work, you haven’t done the right thing by them. So it really is about treating them as a whole person, taking a holistic approach, managing all of those things and not assuming they’ve all come about as a result of the gender distress.

I think some people get frustrated about the conclusion being, well, what these kids need is more holistic care and mental health support, when that system doesn’t exist. What do you say to that?

We’re failing these kids and we’re failing other kids in terms of the amount of mental health support we have available. That is a huge problem — not just for gender-questioning young people. And I think that’s partly a reflection of the fact that the system’s been caught out by a growth of demand that is completely outstripping the ability to provide it.

We don’t have a nationalized health care system here in the United States. We have a sprawling and fragmented system. Some people have reached the conclusion that, because of the realities of the American health care system, the only way forward is through political bans. What do you make of that argument?

Medicine should never be politically driven. It should be driven by evidence and ethics and shared decision-making with patients and listening to patients’ voices. Once it becomes politicized, then that’s seriously concerning, as you know well from the abortion situation in the United States.

So, what can I say, except that I’m glad that the U.K. system doesn’t work in the same way.

-

When asked after this interview about Dr. Cass’s comments, Dr. Hoffman, the A.A.P.’s president, said that the group had carefully reviewed her report and “added it to the evidence base undergoing a systematic review.” He also said that “Any suggestion the American Academy of Pediatrics is misleading families is false.”

--

[liminalweirdo]

#1 – Denial – Pretending a problem does not exist to provide artificial relief from anxiety. Examples:

“During COVID” or “During the pandemic” (past tense)

“The pandemic is over”

“Covid is mild”

“It’s gotten milder”

“Covid is now like a cold or the flu”

“Masks don’t work anyway”

“Covid is NOT airborne”

“Pandemic of the unvaccinated”

“Schools are safe”

“Children don’t transmit COVID”

“Covid is mild in young people”

“Summer flu”

“I’m sick but it’s not Covid”

Taking a rapid test only once

Using self-reported case estimates (25x underestimate) rather than wastewater-derived case estimation

Using hospitalization capacity estimates to enact public health precautions (lagging indicator)

Citing mortality estimates rather than excess mortality estimates. Citing excess mortality without adjusting for survivorship bias.

#2 – Projection – When someone takes what they are feeling and attempts to put it on someone else to artificially reduce their own anxiety. Examples:

“Stop living in fear.” (the attacker is living in fear)

“You can take your mask off.” (they are insecure about being unmasked themselves)

“When are you going to stop masking?”

“You can’t live in fear forever.”

#3 – Displacement – When someone takes their pandemic anxiety and redirects their discomfort toward someone or something else. Examples:

Angry, seemingly inexplicable outbursts by co-workers, strangers, or family

White affluent people caring less about the pandemic after learning that it disproportionately affects lower-socioeconomic status people of color

Scapegoating based on vaccination status, masking behavior, etc.

“Pandemic of the unvaccinated”

Vax and relax

“How many of them were vaccinated?” (troll comment on Covid deaths or long Covid)

Redirecting anxiety about mitigating a highly-contagious airborne virus by encouraging people to do simple ineffective mitigation like handwashing

“You do you” (complainers are the problem, not Covid)

Telling people to get vaccinated or take other precautions against the flu or RSV but not mentioning Covid

Parents artificially reducing their own anxiety by placing children in poorly mitigated environments

Clinicians artificially reducing their own anxiety by placing patients in poorly mitigated environments

Housework to distract from stress

Peer pressure not to mask

#4 – Compartmentalization – Holding two conflicting ideas or behaviors, such as caution and incaution, rather than dealing with the anxiety evoked by considering the incautious behaviors more deeply (hypocrisy)

Examples:

Hospitals and clinicians claim to value health/safety but then don’t require universal precautions

Public health officials claim to value evidence but then give non-evidence based advice (handwashing over masking), obscure or use low-value data over high-quality data (self-reported case counts over wastewater), etc.

Getting a flu vaccine but not a Covid vaccine

Interviewing long Covid experts who recommend masking in indoor public spaces but then going to Applebee’s

Masking in one potentially risky setting (grocery store) but not masking in another similar or more-risky setting (classroom)

Infectious disease conference where people are unmasked

Long Covid and other patient-advocacy meetings where only half the people mask

In-person only EDI events

Not testing because it’s just family

Mask breaks

#5 – Reaction formation – expressing artificial positive feelings when actually experiencing anxiety

Examples:

“It’s good I got my infection out of the way before the holidays”

“I had Covid but it was mild”

Anything quoted in Dr. Jonathan Howard’s book, “We Want Them Infected: How the Failed Quest for Herd Immunity Led Doctors to Embrace Anti-Vaccine Movement”

Herd immunity (infections help)

Hybrid immunity (infections help)

“It’s okay because I was recently vaccinated”

“Omicron is milder”

“Textbook virus”

“Building immunity”

#6 – Rationalization – Artificially reducing Covid anxiety through a weak justification. Examples:

“I didn’t mask but I used nasal spray”

“I don’t need to mask because I was recently vaccinated”

“It finally got me.”

“You’re going to get Covid again and again and again over your life.”

“It’s not Covid because I don’t have a sore throat.”

“It’s not Covid because I took a rapid test 3 days ago.”

“It’s not Covid because I’m vaccinated.”

“Airplanes have excellent ventilation.”

“I’ve had Covid three times. It’s mild.”

“Verily was cheaper.”

“Nobody else is masking.”

“Nobody else is testing.”

“My roommates don’t take any precautions, so there’s no point in me either.”

“I have a large family, so there’s no point in taking precautions.”

Surgical masks (they are actual “procedure masks,” by the way)

Various pseudo-scientific treatments used by the left and right

Handwashing as the primary Covid public health recommendation

Droplet transmission as a thing

Public health guidance that begins with “data shows” (sic)

Risk maps that never turn deep red

5 expired rapid tests

“Masks recommended” instead of universal precautions

“Seasonal”

#7 – Intellectualization – using extensive cognitive arguments to artificially circumvent Covid anxiety Examples:

Unending threads to justify indoor dining

Data-rich public health dashboards that use low-quality metrics and/or don’t change public health recommendations as risk increases

The entire justification for “off-ramps”

Oster, Wen, Prasad

Schools denying air cleaners because it “could make children anxious”

Schools not rapid testing this surge because it “could make children anxious”

The mental gymnastics underlying the rationales for who can get vaccinated, how frequently, or with what brand

Service workers told not to mask because it could make clients uncomfortable

“What comorbidities did they have?”

“The vulnerable will fall by the wayside”

Musicians and others holding large indoor events

5-day isolation periods

Here's a link to the full book, a newer edition than what I own. The information on defense mechanisms begins on textbook page 100. Please let me know if there's a more accessible alt-text solution that you would prefer so I can do better next time."

- Mike Hoerger, PhD MSCR M

source

If you actually got to the end of this and don't remember what you're reading because the cognitive dissonance surrounding covid being "over" is so extreme, it's a list of the ways people downplay covid without any science-backed evidence. How many things on this list do you say, do, or believe?

[ivansergeyevichturgenev]

i don't know how people go through life and think suicide is completely unthinkable as an action. it's an obvious answer to many problems. is it a great one? probably not in a lot of cases. i mean i'm glad i'm still alive and am surprised i feel that way but i will always deeply empathize with suicidality because it felt like nobody got it. and most people don't. i think most clinicians have it wrong i think most advocacy organizations have it wrong i think most families have it wrong. people find it very distressing that suicidality may not always be irrational. it is a very miserable experience but not always misguided

[ledenews]

Trinity's Dr. Suresh Srinivasan to Discuss Pain Awareness Month

He's all about the blend of medical innovation, evidence-based medicine, and compassion to meet each patient’s individual goals when it comes to creating medical methods to relieve a person's pain, and that's exactly what Dr. Suresh Srinivasan will discuss this afternoon on River Talk 100.1 FM. According to his biography on Trinity Health System's website, "Dr. Srinivasan and his team cares for his patients as if they were his own family members, spends time with them to allow for a thorough evaluation and tailors the treatment plans that fit the unique needs of the patients. His goal is not only to reduce pain but restore functionality and help his patients to achieve their treatment goals. Dr. Srinivasan strongly believes patient’s motivation and commitment in managing their pain in partnership with clinician is the integral part of treatment success." He's trained in general surgery and anesthesiology, and he enjoys being on the local River Talk airwaves to discuss healthcare topics that are important to the people here in the Upper Ohio Valley. This afternoon, Dr. Srinivasan will explain Pain Awareness Month as well as touch upon several related topics. To help prepare local listeners, Dr. Srinivasan offers the following information. Dr. Srinivasan’s practice philosophy is to blend medical innovation, evidence-based medicine and compassion to meet each patient’s individual goals. Dr. Srinivasan and his team cares for his patients as if they were his own family members, spends time with them to allow for a thorough evaluation and tailors the treatment plans that fit the unique needs of the patients. Understanding Pain Awareness Month: A Time for Education and Advocacy Every September, Pain Awareness Month is observed to bring attention to the millions of people who suffer from chronic pain and to promote better understanding of pain management strategies. Chronic pain affects more than 50 million Americans, according to the CDC, and approximately 17 million adults live with pain that frequently limits their life or work activities. Pain is the number one reason people go to the hospital, making it a major public health issue. By raising awareness, this month serves as a reminder that pain management and treatment are essential aspects of healthcare that require continued research, education, and advocacy. The Prevalence and Impact of Chronic Pain Chronic pain is defined as pain that persists for more than three months and can significantly impact a person’s quality of life. Conditions like arthritis, fibromyalgia, migraines, and neuropathy are just a few examples of what millions of people endure daily. Pain is the leading cause of long-term disability in the United States, and it is estimated that 14 million people are unable to work due to chronic pain. The economic burden is staggering, with chronic pain costing an estimated $635 billion annually in medical expenses and lost productivity. The physical toll is often accompanied by emotional and psychological distress, as chronic pain frequently leads to depression, anxiety, and isolation. Many patients also face challenges accessing effective pain management, which only exacerbates their suffering. Pain Management Strategies: Moving Beyond Opioids For many years, opioids were commonly prescribed to manage chronic pain. However, the opioid epidemic has highlighted the dangers of long-term opioid use, including addiction and overdose. Pain Awareness Month encourages the exploration and implementation of alternative pain management strategies that are safer and more effective in the long term. These may include physical therapy, psychological counseling, non-opioid medications, and cutting-edge interventional techniques like neuromodulation, spinal cord stimulation, and minimally invasive spine procedures. At Trinity Health System, Dr. Srinivasan, an expert in neuromodulation, and his team offer these advanced procedures to treat chronic pain, providing patients with the most up-to-date options to manage their conditions effectively. The Role of Neuromodulation in Pain Management Neuromodulation techniques, such as spinal cord stimulation, dorsal root ganglion stimulation, and peripheral nerve stimulation, have revolutionized the way chronic pain is treated. These therapies work by modulating the nervous system’s response to pain signals, providing significant relief for patients who have not responded to conventional treatments. In the Ohio Valley, where opioid addiction and chronic pain are significant issues, these advanced techniques have offered a transformative solution. By reducing reliance on opioids, neuromodulation provides chronic pain sufferers with relief while minimizing the risks associated with long-term medication use. Pain Awareness Month is an opportunity to promote awareness of these advanced therapies and their potential to improve patients’ quality of life. Advocating for Improved Access and Education Despite the advancements in pain management, many patients still struggle to access the care they need. Insurance coverage, availability of specialists, and geographic barriers often limit patients’ ability to receive effective treatment. Pain Awareness Month underscores the importance of advocating for improved access to comprehensive pain care. Healthcare professionals, patients, and policymakers must work together to ensure that pain management strategies are accessible, affordable, and evidence-based. Additionally, ongoing education for both healthcare providers and patients is crucial in fostering a better understanding of pain and its treatment options. Conclusion: The Importance of Pain Awareness Pain Awareness Month serves as a vital reminder of the importance of addressing chronic pain as a significant public health issue. By promoting education, advancing pain management techniques, and advocating for better access to care, we can improve the lives of those living with chronic pain. September is a time to reflect on how far we’ve come in pain management and to recognize the ongoing need for research, advocacy, and innovation to help millions find relief from their suffering. Read the full article

[drrogerjou]

CASY Cultural Autism Studies at Yale (the ethnography project led by Dr. Dawn Prince-Hughes) is delighted to welcome Mark Dooley, MA, MES, LMHC, CMHS on Tuesday, September 10, 3-4 p.m. EDT (12-1 p.m. PDT). There is no cost to attend, and international participants are welcome. RSVP online though our borderless Meetup group https://tinyurl.com/c4ezrskr

DESCRIPTION: Autism Discovery. Mark will be facilitating this Autism identity workshop on discovery, phase one of his DAIE model. Expect an interactive, free-form group conversation about individual experiences and shared phenomena of learning our Autism, from which we may illuminate common and unique themes of Autistic identity for sake of CASY’s ethnography. Mark’s future workshops will follow with the phases of acceptance, integration, and expression (more about DAIE in his bio).

BRIEF BIO (provided by the speaker): Mark Dooley is an autistic psychotherapist. He received his Master’s in Clinical Psychology from Antioch University Seattle in 2002, and earned a Master’s in Environmental Studies from The Evergreen State College in 1993. Mark is a Licensed Mental Health Counselor, Child Mental Health Specialist, WA State Approved Clinical Supervisor, WA State Coalition of Sexual Assault Programs Provider, and a Neurodivergent Affirming Clinician. In 2023, he surpassed 28,000 hours of direct psychotherapy (https://markdooley68.com), including psychiatric inpatient, intensive outpatient, integrated healthcare, wilderness, in-home, and private practice settings. Mark recently presented his Discovery / Acceptance / Integration / Expression (DAIE) model of Autistic identity to the Cultural Autism Studies at Yale Ethnography Project. Full video available here https://youtu.be/8kCMLu76b1o

Since 1986, Mark Dooley has worked and studied in the fields of advocacy, social justice, ecology, and mental health. Along with his clinical training and experience, Mark’s therapy utilizes graduate research on mutually healing relationships with nature, and is informed by mindfulness, travel, friendship, and family. To learn more about his work, please visit him at https://www.consultautism.com/

About CASY Cultural Autism Studies at Yale (the ethnography project led by Dr. Dawn Prince-Hughes). An 'ethnography' is an exploration of how a group of people express themselves in a cultural way. Autistic people have a growing kind of culture, and each autistic experience is a vital part of it. Dr. Dawn Prince-Hughes is an anthropologist, ethnographer, primatologist, and author who is autistic. Join her for an exploration of the importance of autistic self-expression and the culture that grows from it. Those who wish to share their content are free to do so on our private Facebook group (see below), organically contributing to a growing autistic culture.

Links to online events will also be shared on these private Facebook groups: SOCIAL CONNECTIVITY FOR AUTISM (http://tinyurl.com/mrxnxmnc) or CASY Cultural Autism Studies at Yale (http://tinyurl.com/4ckbyut7).

CREDITS: The preparation of this material was financed under an agreement with the Connecticut Council on Developmental Disabilities (CTCDD). CASY Sparks membership, activities and events are free. CASY Sparks is sponsored in part by The Daniel Jordan Fiddle Foundation Adult Autism Research Fund, and a generous gift from the Rosen family, and the research of Dr. Roger Jou, including Simons Foundation Powering Autism Research (SPARK) Clinical Site Network - Yale University (https://www.SPARKforAutism.org/Yale).

[anandrajivbakshi]

Dr. Gorav Gupta:

The Best Psychiatrist in Delhi and Visionary Behind Tulasi HealthcareIn the heart of Delhi, amidst the hustle and bustle of city life, stands a beacon of hope and healing for those grappling with mental health challenges. This beacon is Dr. Gorav Gupta, widely regarded as the best psychiatrist in Delhi. As the owner of Tulasi Healthcare, Dr. Gupta has not only transformed the lives of countless individuals but also significantly advanced the field of mental health in India.#### A Distinguished JourneyDr. Gorav Gupta’s journey to becoming a leading psychiatrist began with an unwavering commitment to medical excellence. His rigorous academic background, including an MBBS and specialization in psychiatry, laid a strong foundation for his career. Dr. Gupta's passion for understanding the intricacies of the human mind and his empathetic approach to patient care have been the cornerstones of his success.#### Tulasi Healthcare: A Sanctuary for Mental WellnessDr. Gupta's vision for mental healthcare materialized with the establishment of Tulasi Healthcare. Recognizing the critical need for comprehensive mental health services, he founded this facility to provide a sanctuary where patients receive holistic and compassionate care. Tulasi Healthcare is renowned for its patient-centered approach, addressing not only the symptoms but also the root causes of mental health issues.#### Comprehensive Mental Health ServicesAt Tulasi Healthcare, Dr. Gupta and his team offer a wide range of services tailored to meet the diverse needs of their patients:- **Inpatient and Outpatient Care**: The facility provides both inpatient and outpatient treatment options, ensuring that patients receive the appropriate level of care. The inpatient program offers a structured environment for those requiring intensive support.- **Psychotherapy and Counseling**: Dr. Gupta emphasizes the importance of therapy in mental health treatment. Tulasi Healthcare offers various forms of counseling and psychotherapy, including cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), and family therapy.- **Medication Management**: With careful evaluation and monitoring, Dr. Gupta ensures that patients receive effective medication management, minimizing side effects and optimizing therapeutic outcomes.- **Rehabilitation Programs**: For individuals struggling with substance abuse and addiction, the center provides comprehensive rehabilitation programs that integrate medical treatment with psychological support and life skills training.#### A Commitment to Advocacy and AwarenessDr. Gupta is not only a clinician but also a staunch advocate for mental health awareness. He regularly conducts workshops, seminars, and public speaking engagements to educate the community about mental health issues and reduce the stigma associated with mental illness. His advocacy efforts have been instrumental in fostering a more informed and empathetic society.#### Patient-Centric ApproachWhat sets Dr. Gupta apart as the best psychiatrist in Delhi is his unwavering commitment to his patients. His approach is deeply empathetic, ensuring that each patient feels heard, understood, and supported. Patients and their families often share stories of the profound impact Dr. Gupta has had on their lives, highlighting his dedication to their well-being.#### Innovative and Future-FocusedDr. Gupta is committed to staying at the forefront of psychiatric research and treatment. He continuously integrates the latest advancements in mental health care into his practice, ensuring that his patients benefit from cutting-edge treatments. His forward-thinking approach ensures that Tulasi Healthcare remains a leader in the field.###

https://www.goravgupta.com/psychiatrist-in-delhi/

[gocooool]

Psychiatric Clinic

Exploring the Role of a Psychiatric Clinic in Mental Health Care

Psychiatric clinics play a vital role in the landscape of mental health care, providing crucial services and support to individuals facing various psychological challenges. These clinics serve as safe havens where patients can seek assessment, diagnosis, treatment, and ongoing management of mental health disorders.

At the heart of every psychiatric clinic is a multidisciplinary team of professionals dedicated to the well-being of their patients. Psychiatrists, psychologists, social workers, and psychiatric nurses collaborate to offer comprehensive care tailored to each individual's needs. This holistic approach not only addresses immediate symptoms but also focuses on long-term recovery and improved quality of life.

One of the primary functions of a psychiatric clinic is diagnosis. Through thorough evaluations and assessments, clinicians identify mental health conditions such as depression, anxiety disorders, bipolar disorder, schizophrenia, and others. These diagnoses form the basis for personalized treatment plans, which may include medication management, psychotherapy, or a combination of both.

Furthermore, psychiatric clinics serve as educational resources for patients and their families. They provide valuable information about mental health conditions, treatment options, coping strategies, and community support services. By empowering patients with knowledge, these clinics foster a sense of control and agency in managing their mental health.

Beyond clinical services, psychiatric clinics contribute significantly to research and advocacy in mental health. They participate in studies to advance understanding of psychiatric disorders and improve treatment outcomes. Additionally, they advocate for policies that promote mental health awareness, reduce stigma, and expand access to mental health care services.

In conclusion, psychiatric clinics are indispensable pillars of support in the realm of mental health care. They provide compassionate care, evidence-based treatment, and essential resources to individuals navigating the complexities of psychiatric disorders. By combining clinical expertise with empathy and understanding, these clinics offer hope and healing to countless individuals and families affected by mental illness. For more details please do visit supreme hospitals, Psychiatric Clinic in Padur

[hupcflorlando]

Nurturing Minds: Exploring the Depths of Child & Adolescent Psychiatry and Therapy

In the ever-evolving landscape of mental health, the importance of understanding and addressing the unique needs of children and adolescents cannot be overstated. Child & Adolescent Psychiatry and Therapy stand at the forefront, offering vital insights and interventions to support the well-being of our youngest generation. Let's explore this crucial field, its significance, approaches, and impact.

Child & Adolescent Psychiatry and Therapy encompass a spectrum of specialized care tailored to young minds' developmental stages and psychological intricacies. From infancy through adolescence, these formative years lay the foundation for future emotional, cognitive, and social functioning. Recognizing and addressing mental health challenges during this critical period can profoundly influence a child's trajectory and overall quality of life.

At the heart of Child & Adolescent Psychiatry and Therapy lies a deep understanding of developmental psychology, neurobiology, and family dynamics. Clinicians in this field are equipped with the expertise to assess, diagnose, and treat a wide range of conditions, including anxiety disorders, depression, ADHD, autism spectrum disorders, and trauma-related disorders.

One of the key principles guiding Child & Adolescent Psychiatry and Therapy is the recognition of the interconnectedness between biological, psychological, and social factors in shaping mental health outcomes. This holistic approach ensures that interventions are comprehensive and tailored to address the multifaceted needs of each young individual.

Early intervention is a cornerstone of effective Child & Adolescent Psychiatry and Therapy. By identifying and addressing mental health concerns in their nascent stages, clinicians can mitigate the risk of long-term impairment and enhance resilience. Moreover, empowering children and adolescents with coping skills and emotional regulation strategies equips them with invaluable tools to navigate life's challenges.

In recent years, there has been a growing emphasis on evidence-based practices within Child & Adolescent Psychiatry and Therapy. Rigorous research and clinical trials have yielded insights into the efficacy of various interventions, ranging from cognitive-behavioral therapy and medication management to family-based interventions and school-based programs. By leveraging these evidence-based approaches, clinicians can optimize outcomes and ensure that young individuals receive the most effective care available.

Child & Adolescent Psychiatry and Therapy also play a pivotal role in fostering collaboration among diverse stakeholders involved in the lives of children and adolescents. This includes parents, educators, pediatricians, social workers, and community organizations. By working together in a coordinated manner, these stakeholders can create a supportive ecosystem that promotes positive mental health outcomes and fosters resilience in young individuals.

In light of the evolving landscape of technology and digital media, Child & Adolescent Psychiatry and Therapy are also adapting to meet the unique challenges posed by the digital age. Clinicians are increasingly addressing issues such as screen time management, cyberbullying, and the impact of social media on young people's mental health. By staying abreast of these emerging trends and integrating technology into therapeutic interventions, clinicians can better engage with today's youth and address their evolving needs.

It is important to recognize that access to Child & Adolescent Psychiatry and Therapy services remains a significant challenge for many young individuals and their families. Barriers such as stigma, financial constraints, and limited availability of specialized providers can hinder access to timely and appropriate care. Addressing these disparities requires a concerted effort from policymakers, healthcare systems, and advocacy organizations to ensure that all children and adolescents have access to high-quality mental health services when they need them.

[marketsandmarkets-events]

Challenges and Triumphs in Rare Disease Care: From Diagnosis to Orphan Drugs

In the vast realm of medicine, there exists a hidden world of rare diseases, often overshadowed by more prevalent health conditions. These diseases, by definition, affect a small percentage of the population, yet their impact is profound and far-reaching. What sets them apart is not just their rarity but the challenges they pose in diagnosis, treatment, and research. Fortunately, the emergence of orphan drugs has provided a ray of hope for those affected by these conditions, offering targeted therapies and renewed optimism.

Rare diseases, also known as orphan diseases, collectively encompass thousands of different conditions, each with its own unique set of symptoms, prognosis, and treatment needs. While individually rare, together they affect millions worldwide, often striking children and young adults with debilitating effects. From genetic disorders like cystic fibrosis and Huntington's disease to metabolic conditions such as Gaucher disease and lysosomal storage disorders, the spectrum of rare diseases is vast and varied.

Register for Orphan Drugs and Rare Diseases Conference – US Edition @ https://bit.ly/3VvstRr

One of the primary challenges in tackling rare diseases lies in their diagnosis. Due to their infrequency and often nonspecific symptoms, patients may endure years of uncertainty and misdiagnosis before receiving a definitive answer. This diagnostic odyssey not only takes a toll on patients and their families but also delays crucial interventions and support. However, advancements in genetic testing and molecular diagnostics have revolutionized the diagnostic process, enabling healthcare providers to pinpoint rare diseases more accurately and swiftly than ever before.

Once diagnosed, the next hurdle is finding effective treatments. Traditional drug development processes are often unsuitable for rare diseases due to the small patient populations and limited financial incentives for pharmaceutical companies. Recognizing this gap, regulatory agencies around the world have implemented incentives to encourage the development of orphan drugs—medications specifically designed to treat rare diseases. These incentives may include market exclusivity, tax credits, and research grants, providing a lifeline for researchers and pharmaceutical companies venturing into this uncharted territory.

The advent of orphan drugs has ushered in a new era of hope for those living with rare diseases. These drugs, tailored to address the underlying mechanisms of each condition, offer the promise of improved outcomes and quality of life. From enzyme replacement therapies for lysosomal storage disorders to gene therapies for inherited retinal diseases, orphan drugs are transforming the treatment landscape and bringing relief to patients who once had few options.

Moreover, orphan drugs not only benefit patients with rare diseases but also contribute to our understanding of human biology and disease mechanisms. The research and innovation spurred by orphan drug development have implications beyond rare diseases, shedding light on broader medical challenges and paving the way for novel therapies across various fields.

Become a Sponsor @ https://bit.ly/3yInnrQ

Despite these advancements, significant obstacles remain on the journey to conquer rare diseases. Access to orphan drugs, particularly in low-income countries, remains a pressing issue, with affordability and availability often posing barriers to treatment. Additionally, the complexity of rare diseases necessitates collaborative efforts across disciplines, involving clinicians, researchers, advocacy groups, and policymakers to drive progress and improve outcomes.

In this pursuit, patient advocacy plays a pivotal role, amplifying the voices of those affected by rare diseases and advocating for greater awareness, research funding, and access to care. Through grassroots initiatives, online communities, and global networks, patients and their families are driving change and shaping the future of rare disease research and treatment.

In conclusion, the world of rare diseases and orphan drugs is one of resilience, innovation, and hope. While the journey is fraught with challenges, each breakthrough brings us closer to unraveling the mysteries of these conditions and offering solace to those in need. By fostering collaboration, investing in research, and prioritizing patient-centered care, we can continue to illuminate the path forward, one discovery at a time.

Become a Speaker @ https://bit.ly/3R9CNvS

[theembcnetwork]

Dr. Cheryl BryantBruce MD Interviews Vyshika Willis - Medical Chat from THE EMBC NETWORK on Vimeo.

Cheryl Bryant Bruce M.D. (thecelebritydoc.net) In this video, learn more about Vyshika M. Willis, M.A., a licensed Marriage, Family, Couple Therapist in Oregon. Serving the Portland community, she focuses on the mental well-being of the African diaspora as a mental health clinician at OHSU. With a systemic and relational lens, she is dedicated to advocating for underrepresented and underprivileged individuals, offering psychoeducation locally and nationally. Through her platform, she initiates conversations to reduce stigma and increase awareness of mental health resources in the Black community. Stay tuned to discover more about her journey and passion for mental health advocacy. #VyshikaMWillis#AfricanDiaspora#BlackMentalHealth#MentalHealthAdvocate#BlackTherapist#LicensedTherapist#Psychotherapy#MentalHealthAwareness#BlackTherapy#MentalHealth#MentalWellness#MentalHealthServices#MentalHealthSupport#Wellness#Therapy#Empowerment#Counseling#Healing#SelfLove#SelfCaree (42) Vyshika Willis, M.A. | LinkedIn

[khetho-040517]

My reflection on my experience of Advocating for patients.

Patients typically find themselves navigating a maze of procedures, diagnoses, and treatments in today's complex network of healthcare, their voices sometimes drowned out by the complexities. Advocating for patients in this system is like being a guiding light in the fog, illuminating pathways, amplifying voices, and ensuring that, despite the language and protocols, the human element is never forgotten. It is about advocating for people's rights, dignity, and well-being and empowering them to actively engage in healthcare decisions. Patient advocates play an important role in establishing a healthcare environment that welcomes everyone’s journey with empathy, understanding, and support, from ensuring access to quality care to campaigning for equal treatment. In this blog Am going to share my experience in advocating for my clients in Prince Mshiyeni Memorial Hospital.

Being a healthcare clinician means that you are the mouth and eyes of every patient in the hospital. In my clinical practical so far, I’ve realised the importance of seeking to help from other healthcare teams to intervene in the clients’ health to improve functional or medical outcomes. One of my patients had a spinal cord injury, was paraplegic, and was in the rehabilitative phase of treatment. He was referred to OT from physiotherapy for rehabilitation to ADLS and IADLS. The patient had a good functional and medical prognosis, but the rehabilitation wasn’t adequate without the wheelchair thus I had to advocate for a wheelchair so that he would be able to mobilize independently. However, the client was discharged without the wheelchair due to a delay in ordering and the tight budget that the hospital has for wheelchairs. I couldn’t believe it, but when I made a follow-up, the physio said that they would call him when the wheelchair arrived and that would be after 8 weeks. Advocating for clients can be difficult sometimes because the request on behalf of the client can take a long time to be fulfilled and sometimes it’s not considered which could be due to a broken Multidisciplinary team in the healthcare system.

I’ve learned that not everything that my patient requests should be advocated because I know what is best for my client to become functionally independent. One of my recent clients has paraparesis and presents with poor static sitting balance as one of the impaired client factors therefore I advocated and asked the nurses in the ward to not feed her as she can do it independently and should be allowed to sit. However, this was not considered because when I came to the ward again, I found her being fed by the nurse while lying supine. This demoralized me and I felt like the nurses were not taking me seriously because am just a student OT, but I overcame that with the help of my supervisor and pushed the client into sitting at the edge of the bed to eat. This led me to think that being a healthcare student sometimes it’s hard to advocate because the hospital staff takes us lightly, however, this motivates me to do what is best for my clients irrespective of what they may think.

TYPES OF PATIENT ADVOCACY.

Medical advocacy

This includes making the client understand their diagnosis by translating medical conditions to them and their families.

I explained to the burn’s patient about the importance of the drinking the nutrient juice offered by a dietician to heal the skin.

Medical facility advocacy

Includes nurses and social workers who act as mediators between patients and physicians. They ensure that patients have safe accommodation etc.

I advocated for the paraparesis patient that she should be always put in sitting when eating to facilitate the development of trunk muscles to improve static sitting balance.

Health insurance advocacy

This includes assisting patients with benefits such as medical prescription, vision, Medicare/Medicaid, Veterans Affairs, social security, and home health.

Family Advocacy

This includes mediating conflicts between patients and their family members regarding medical treatment decisions.

Legal Advocacy

It includes helping individuals claim disability grants, work compensation or malpractice, and medical arrow review.

Transitions and Housing Placement advocacy

They aid in shifting to assisted living facilities, nursing homes, skilled nursing facilities, and adult family homes.

I advocated for the SCI patient’s family to change their home setting so that the patient would still have access to different areas of the house. This included putting rails in the toilet, building a ramp, and putting his most important daily use items lower to facilitate reaching.

Mental and behavioural health and social work advocacy

Mental and behavioural health and social work advocates assist patients in managing severe health conditions, addiction disorders, and communication difficulties caused by mental or behavioural obstacles. They can also consult with patients on relevant drugs and therapy.

I advocated for the burns patient by referring him to a psychiatrist after a reported psychic behaviour in the ward. It was found that he had a history of delirium but is currently psychotic.

Pain management Advocacy

This includes ensuring that pain is managed properly by recommending a change in the dosage or type of medication.

I advocated for my paraplegic patient who had pain in the stomach due to constipation by asking the doctor to provide the client with bisacodyl.

As I conclude and linking back to the aim of the introduction, I would say I've learned a lot about the importance of advocacy for clients and I wish to get more exposure to different conditions in the future so that I can develop advocacy skills that will link to different clients. I highly recommend it in the healthcare system or Multidisciplinary Team.

REFERENCES

References Dhillon, S. K., Wilkins, S., Law, M. C., Stewart, D. A., & Tremblay, M. (2010). Advocacy in Occupational Therapy: Exploring Clinicians’ Reasons and Experiences of Advocacy. Canadian Journal of Occupational Therapy, 77(4), 241–248. https://doi.org/10.2182/cjot.2010.77.4.6

Dhillon, S., Wilkins, S., Stewart, D., & Law, M. (2015). Understanding advocacy in action: A qualitative study. British Journal of Occupational Therapy, 79(6), 345–352. https://doi.org/10.1177/0308022615583305

Types of Patient Advocacy. (n.d.). Www.painscale.com. https://www.painscale.com/article/types-of-patient-advocacy

[religion-is-a-mental-illness]

By: Lisa Selin Davis and LGB Courage Coalition

Published: Apr 25, 2024

“Every major medical association supports gender-affirming care.” You’ve likely heard this talking point from activist organizations defending gender medicine for children and adolescents: puberty blockers, cross-sex hormones, and sometimes surgery to treat gender dysphoria.

I don’t deny that American medical associations—advocacy groups that support clinicians—take this position. But I do argue that the position is not rooted in science or reality, and that it can harm the very patients it purports to help—especially gender nonconforming and gay and lesbian young people. 

Now, a nearly 400-page report, commissioned by England’s National Health Service, backs these assertions up. 

The Cass Review, which took four years to complete, comes in response to complaints about the only public youth gender clinic in England and Wales, Gender Identity Development Service, or GIDS, which was shut down last year—that they were fast-tracking kids into irreversible medical interventions, and that the culture of fear prevented concerned clinicians from speaking up. Cass and her team needed to understand the current landscape to come up with a plan to fix it. So they listened to trans people, detransitioners, therapists who feel pressure to affirm, doctors who passionately support these treatments, and many others with differing opinions. They also commissioned systematic reviews of the evidence about both psychological and medical interventions.

Here’s just some of what they found: 

• No one had followed up with the 9,000 children who’d gone through the service—and, shockingly, the adult gender clinic would not share the data about how they fared later. 

• There was no clinical consensus about how to treat them. “Clinicians who have spent many years working in gender clinics have drawn very different conclusions from their clinical experience about the best way to support young people with gender-related distress,” Cass wrote.

• The evidence to support medical transition for youth was “remarkably weak.” “The reality is that we have no good evidence on the long-term outcomes of interventions to manage gender-related distress,” Cass admitted. That includes the evidence around the use of puberty blockers, which the NHS has now largely banned, and their effects on bone health, brain development, and fertility.

• Of great importance is what some of that stronger evidence showed: a correlation between child-onset gender dysphoria and later homosexuality. “The majority of these children [in the studies] became same-sex attracted, cisgender adults,” Cass writes. In the one Dutch study upon which all gender medicine is based, 89 percent of the young people who transitioned “were same-sex attracted to their birth-registered sex, with most of the rest being bisexual. Only one patient was exclusively heterosexual.” 

Some parents had told Cass that their children had “been through a period of trans identification before recognising that they were cisgender same-sex attracted. Similar narratives were heard from cisgender adults.” Among the studies cited in the Review is one of almost 3,000 adolescents, whose high amount of “gender non-contentedness” in early adolescence had declined by early adulthood—but that non-contentedness “was also more often associated with same-sex attraction.” 

LGBT Courage Coalition co-founders Jamie Reed and Aaron Kimberly both experienced gender dysphoria as girls and adolescents. Both grew up to be same-sex attracted. Aaron went on to transition as an adult; Jamie went on to marry a trans man. My child is as gender nonconforming as Jamie and Aaron were—but no one can predict her future based on that. And perhaps her lack of gender dysphoria is related to growing up in a time and place and family in which that gender nonconformity is completely accepted, without anyone trying to make meaning from it.

Of great import to me as a parent is that most kids in the original cohort studied in the Netherlands were likely gay. But the medicines they received were the same as those once given to gay adults to punish them or cure them of their sexual proclivities. Somehow, these treatments are touted as being safe and effective for “LGBTQ+ kids,” but the reality is that they can sterilize and remove sexual function from same-sex attracted people—something they’ve been fighting for decades to stop.

Instead of talking openly about these hugely important issues with youth gender medicine, those who advocate for it have insisted on “no debate.” But debate we must. Because today, many more kinds of kids seek these interventions. There has been an “exponential change in referrals over a particularly short five-year timeframe,” Cass reports, with girls quite suddenly making up the bulk of patients, instead of boys—a shift that cannot be explained by increasing social acceptance. Meanwhile, children and adolescents “are on a developmental trajectory that continues to their mid-20s”—that is, it’s hard to make grand decisions during this long period of growth and change.

The youth cohort sheltered beneath the umbrella of “trans” is actually a heterogeneous group, and the inconvenient truth is that no one knows the best way to help them thrive. No one knows who they will grow up to be or how they will identify in adulthood. Nor does anyone know the benefits or harms of social transition, in which children adopt the gender identity that doesn’t correspond with their sex. “However, those who had socially transitioned at an earlier age and/or prior to being seen in clinic were more likely to proceed to a medical pathway,” Cass notes. That is, it is not a neutral intervention, but rather an active one that seems to increase the likelihood of medicalizing later. 

Cass states clearly that “For the majority of young people, a medical pathway may not be the best way” to achieve self-actualization. She supports expanding psychological support for those young people, and strict and standardized evaluations, in line with what several other European countries are doing. She demands long-term follow-up not only of anyone who will transition in the future, but of those who already have.

The World Professional Association for Transgender Health, an advocacy and activist organization that appointed itself the generator of “standards of care”—and which England and other European countries are increasingly rejecting—directed people toward an opinion piece called “The Cass Review: Cis-supremacy in the UK’s approach to healthcare for trans children.” In other words, they dismiss the whole thing as bigotry. But Cass dismissed their own standards of care as lacking “developmental rigor.”

The NHS thanked Cass for her work and suggested that it may have international influence. I hope so, too. The report makes clear that the American affirmative model was a departure from a more cautious approach, and that even the cautious approach was based on substandard evidence—that modifying secondary sex characteristics in adolescents, or transitioning children to live as the opposite (or neither) sex was never fully supported by any high-quality research and became more about social justice than evidence. But medicine, Cass reminds us, is in fact evidence based. The issue is “about what the healthcare approach should be, and how best to help the growing number of children” with gender distress. It is not about ideology.

We don’t have the same system in America. We don’t have the kind of centralized healthcare and state agencies to craft guidelines that all must follow. Here, we battle it out in the legislature, state by state, red against blue, based on moral worldviews more than evidence. So how will the Cass Review influence our toxic gender culture war? How will they affect the medical associations that craft guidelines and create policy statements?

I queried the American Academy of Pediatrics, which recently reaffirmed its commitment to the affirmative model; the American Psychiatric Association; and the American Psychological Association, which have pro-affirmation models statements of their own. Only the latter responded, and I spent over an hour talking to APA Senior Advisor, Psychology in the Public Interest, Clinton Anderson. He admitted to the low quality of evidence and said that there’s a fundamental tension between those who view transition as a social justice issue and those who advocate for a more cautious, evidence-based approach. Where does the APA land? “Our concern has been largely about a human rights issue, and the way this is treatment has become politicized in our system and used as a punishment against people for being different,” Anderson told me. “And that I think has to be seen as the biggest issue.”

I disagree. But I will say that Anderson listened to my points more than anyone at these institutions ever has. I urged him to take a closer look at the Cass Review, and to listen to those who’ve been hurt, not just those who feel they’ve been helped. Maybe, just maybe, he heard me. Maybe, just maybe, these associations hear the science-minded and nuanced words of the Cass Review.

[influencermagazineuk]

Dr. A.J. Layon Pens Book: A People’s Guide to the End of Life

"A Guide for Navigating End-of-Life Care: A Compassionate Approach to Death" Discussing “end of life" can be challenging for many, yet there may arise occasions when we must confront decisions regarding elderly loved one or a family member facing illness. After over three decades of tending to patients in the ICU, Dr. Layon a renowned Critical Care MD in the USA understands the challenges that many families endure.   Written with compassion and insight, "A People’s Guide to the  End of Life" serves as a valuable resource for families facing the imminent passing of a loved one, or for individuals grappling with their own mortality within a complex and often bewildering healthcare system At its core, this book addresses the profound subject of death: how we confront it, how families cope, and how individuals facing their final moments may find solace and understanding. Drawing from decades of experience in Operating Rooms, Intensive Care Units, and Burn Units across the US, Latin America, and Africa, the author was inspired to pen these words by the impending loss of a dear friend and colleague—a passionate advocate for social and economic justice. With a focus on the harsh realities of dying, the book offers clarity and practical guidance to those navigating the healthcare maze amidst confusion and misinformation. It is a vital resource for caregivers, healthcare professionals, and families alike, offering insights gleaned from over 40 years of clinical practice, research, and education. From managing expectations when dealing with medical professionals to navigating complex family dynamics, the book provides real-world examples—both successful and unfortunate—to aid readers during life's most challenging moments. Testimonials speak to the book's impact, with readers finding comfort and guidance in its pages during times of profound transition. “The 'People's Guide to End of Life' played a crucial role for our family during our grandfather's illness. We sought the best care for him, and thanks to Dr. Layon's book, we were equipped to ask the right questions, ensuring our grandfather's comfort.” Sophia T. . Dr. A. Joseph Layon, the author, brings a wealth of expertise to his work as an intensive care physician, drawing from a diverse background in internal medicine, anesthesiology, critical care, and neurocritical care. Trained at prestigious institutions including Grossmont College and the University of California, San Diego, Dr. Layon has served in various capacities throughout his career, from clinician and educator to department chair and internationalist. He has confronted difficult truths within compromised health systems, embodying the ethos of compassionate care and advocacy for those facing life's most challenging moments. In "A People’s Guide to End of Life," Dr. Layon offers not only practical advice but also a compassionate perspective on facing death with dignity and understanding. It stands as a testament to his dedication to easing the burdens of those navigating the journey toward the end of life.  This book is essential, deserving a place in every home library, as it offers invaluable guidance for the future and caring for your loved ones. To Learn More:  https://ajosephlayonmd.com/ Read the full article

[rediscoverhearing]

Finding Hearing Services Near Me

From Broadway shows to the roar of Niagara Falls, New Yorkers know that our sense of hearing is important. But a recent study revealed that while over 95 percent of newborns receive a hospital-based hearing screening through state Early Hearing Detection and Intervention programs, many children don’t get the follow-up testing they need to determine whether they have an hearing impairment, which can be difficult to diagnose without proper technology.

Fortunately, a range of state and national organizations are dedicated to helping individuals with hearing loss find the services they need, including support groups, advocacy and education. In addition to providing access to affordable hearing aids and other devices, they can help with insurance coverage, financing and specialized care.

Most private insurance plans cover part or all of the cost of hearing aids for adults. Check your own policy or talk to a representative at the company to make sure you understand what’s covered and how to access it. In addition, many employer-sponsored health savings accounts (HSAs) allow you to withdraw pre-tax dollars to help pay for hearing aids and other healthcare expenses.

The VA is the largest provider of free hearing aids for Veterans. Its Audiology program recently deployed Enterprise Remote Tuning of Hearing Instruments, which allows for ad hoc tuning of VA-issued hearing aids by a remote clinician from the comfort of the home or clinic. This helps ensure that all Veterans have the best fit for their needs and improves the speed of repair when there is a problem with the device.

If you’re a Veteran, visit this VA clinic locator to find the nearest location near you to get free services and assistance. The site also provides helpful resources for families and friends of a Veteran who is experiencing hearing loss, including information on the latest in assistive technology and resources to support their loved ones’ quality of life.

Throughout the country, community centers offer a range of free hearing services near me for all ages, including educational classes, screenings and consultations with audiologists and other healthcare professionals. In addition, some provide support groups for parents of children with hearing loss and assistive technology loans for low-income families.

In New York, there are over 400 local service centers that help people with disabilities, including hearing loss. Many are staffed by volunteers, and some provide financial grants based on a person’s level of need. The TPA Scholarship Trust for the Hearing Impaired helps those who can’t afford the full cost of hearing devices, medical treatment or rehabilitative services.

The Center for Hearing and Communication is a non-profit organization that helps infants, children and adults with hearing loss. In addition to providing a variety of state-of-the-art devices, the organization offers a wide range of other services, such as audiology and speech therapy and emotional health counseling. It also offers a program that trains dogs to serve as auditory companions for kids with hearing loss and other communication challenges. You can apply for this program online or by calling the organization.

Rediscover Hearing the Joy of Hearing with Your local & WA owned Independent Audiologists. Your local Hearing Aid and Tinnitus Specialists. Combined experience of 38 years.

[viralwritershub]

Why Choose Westville NJ for Your Cancer Care Needs

For those facing the daunting diagnosis of cancer, choosing where to receive care is not a decision made lightly. Patients seek places that offer cutting-edge treatment, specialized care, and a supportive community. When it comes to cancer care, Westville NJ stands out as a healthcare hub that fulfills all these criteria. Boasting a network of top-tier medical facilities, a plethora of holistic treatment options, and a community that rallies around its members, Westville NJ is not just a location but a healthcare ecosystem renowned for its excellence in oncology. In this comprehensive guide, we explore why Westville NJ is an ideal choice for individuals seeking exceptional cancer care.

Local Expertise and Specialized Care

Innovative Medical Facilities

Westville NJ is home to a constellation of hospitals and cancer centers at the forefront of medical innovation. Institutions like Westville Regional Cancer Center and The Excellence Oncology Institute have garnered international recognition for their groundbreaking research and implementation of state-of-the-art treatment protocols. These facilities are not just hospitals; they are beacons of hope that push the boundaries of oncological science, offering patients access to clinical trials and experimental treatments that are not widely available.

Multidisciplinary Approach

Patients in Westville NJ benefit from a multidisciplinary method to cancer care. A collaborative team of clinicians, including oncologists, radiologists, surgeons, and supportive care specialists, work together to develop personalized treatment plans that consider not only the disease but the patient's overall well-being. This approach ensures that no aspect of the patient's care falls through the cracks and that each individual receives comprehensive, coordinated care.

Comprehensive Treatment Options

Conventional Therapies

Westville NJ provides all conventional cancer treatment modalities, from chemotherapy to radiation therapy and surgery. In these facilities, these standard therapies are administered with precision and care, minimizing side effects and maximizing efficacy. The facilities combine cutting-edge technology with the human touch, offering a balance of science and empathy that is vital in cancer care.

Cutting-Edge Research and Therapies

What sets Westville NJ apart is its commitment to pioneering research and the development of new treatment methods. The Institute's Research Division is dedicated to improving cancer outcomes, and this dedication is evident in the cutting-edge therapies such as immunotherapy, targeted therapy, and cutting-edge surgical procedures that are offered to patients. By choosing Westville NJ, patients become part of a community that drives forward the fight against cancer, not just for the individual's benefit but for the advancement of oncology as a whole.

Supportive Community and Resources

Patient-Focused Care

In Westville NJ, patient care is more than just the medical treatment; it's a holistic commitment to the individual's physical, emotional, and psychological well-being. The community is renowned for its patient advocacy, with support groups, counseling services, and integrative medicine programs available to assist patients and their families throughout their cancer journey.

Advanced Palliative and Supportive Care Services

The supportive care services in Westville NJ are second to none, with a focus on improving the quality of life for patients facing serious illness. Palliative care specialists work hand-in-hand with the oncology team to manage symptoms, relieve pain, and provide support, with the aim of enhancing the patient's comfort and well-being.

Patient Testimonials and Success Stories

Real-Life Experiences

There is no better testament to the quality of care in Westville NJ than the voices of those who have navigated their cancer treatment there. Patients from all walks of life share their stories of hope, resilience, and the exceptional care they received in Westville NJ. These narratives serve as inspiration and reassurance for those considering the town for their cancer care needs, illustrating the positive outcomes and the supportive environment that define the local healthcare landscape.

Leading Recovery and Survivorship Programs

For survivors, Westville NJ offers a robust program focused on recovery and long-term survivorship. With a focus on wellness, these programs empower those who have defeated cancer to live life to the fullest, providing the tools and resources to overcome the physical and emotional challenges that may persist beyond treatment.

                                           Choosing cancer care Westville NJ means choosing excellence, innovation, and a community dedicated to supporting patients through one of life's most challenging chapters. With its wealth of medical expertise, comprehensive treatment options, supportive resources, and the beacon of hope presented by successful patient stories, Westville NJ emerges as a leading destination for that requiring cancer care. Whether you are a local resident or considering a move for your treatment, Westville NJ's commitment to compassionate and advanced care makes it a clear choice for anyone seeking to heal from cancer.